"
Team:Debrecen-Hungary/project
From 2010.igem.org
Ophir Keret (Talk | contribs) |
Ophir Keret (Talk | contribs) |
||
| Line 26: | Line 26: | ||
Introduction<br> | Introduction<br> | ||
<br> | <br> | ||
| - | <p | + | |
| - | Our team has decided to focus efforts at making a nuclear hormone receptor kit, for use in eukaryotic cells. Our attention was drawn to this class of receptors due to their key physiological contribution in the endocrine system, cellular differentiation pathways, paracrine signaling and more.< | + | |
| - | Upon ligand binding, nuclear hormone receptors undergo a change in conformation. They then translocate to the nucleus where they bind to specific DNA elements. The binding ultimately leads to defined changes in gene expression (both activation and repression). They may be viewed as special transcription factors which can be activated by extracellular cues. < | + | <p style="text-align: justify; text-indent: 0.5in;">Our team has |
| - | The kit will include various basic parts of which a user might be able to create his own ligand activated transcription factor (a composite part). | + | decided to focus efforts at making a nuclear hormone receptor kit, for use in |
| - | Our primary goal is thorough characterization of each basic part. Our methods and results as well as secondary goals will be addressed at a later time. < | + | eukaryotic cells. Our attention was drawn to this class of receptors due to |
| - | We hope that our biobrick part contribution may be used in a variety of | + | their key physiological contribution in the endocrine system, cellular |
| - | </p> | + | differentiation pathways, paracrine signaling and more.</p> |
| + | |||
| + | <p style="text-align: justify; text-indent: 0.5in;"><span> </span>Upon ligand binding, nuclear hormone receptors | ||
| + | undergo a change in conformation. They then translocate to the nucleus where | ||
| + | they bind to specific DNA elements. The binding ultimately leads to defined | ||
| + | changes in gene expression (both activation and repression). They may be viewed | ||
| + | as special transcription factors which can be activated by extracellular cues. </p> | ||
| + | |||
| + | <p style="text-align: justify; text-indent: 0.5in;">The kit will | ||
| + | include various basic parts of which a user might be able to create his own | ||
| + | ligand activated transcription factor (a composite part). Our primary goal is | ||
| + | thorough characterization of each basic part. Our methods and results as well | ||
| + | as secondary goals will be addressed at a later time. </p> | ||
| + | |||
| + | <p style="text-align: justify; text-indent: 0.5in;">We hope that our | ||
| + | biobrick part contribution may be used in a variety of medicinal applications | ||
| + | as well as environmental sustainability projects or even other fields.</p> | ||
| + | |||
| + | |||
| + | |||
<br> | <br> | ||
<hr> | <hr> | ||
Revision as of 20:30, 12 July 2010
Team
|
|
Abstract
Introduction
Our team has decided to focus efforts at making a nuclear hormone receptor kit, for use in eukaryotic cells. Our attention was drawn to this class of receptors due to their key physiological contribution in the endocrine system, cellular differentiation pathways, paracrine signaling and more.
Upon ligand binding, nuclear hormone receptors undergo a change in conformation. They then translocate to the nucleus where they bind to specific DNA elements. The binding ultimately leads to defined changes in gene expression (both activation and repression). They may be viewed as special transcription factors which can be activated by extracellular cues.
The kit will include various basic parts of which a user might be able to create his own ligand activated transcription factor (a composite part). Our primary goal is thorough characterization of each basic part. Our methods and results as well as secondary goals will be addressed at a later time.
We hope that our biobrick part contribution may be used in a variety of medicinal applications as well as environmental sustainability projects or even other fields.
Measurements
Discussion & Conclusions
References
Acknowledgment
Misc.
